Shane DiGiovanna Act

Hozzl · 2026-04-03T08:05:48Z

Explore the details of House Bill 7877 Shane DiGiovanna Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

4/3/2026, 8:05 AM

Summary of Bill HR 7877

H.R. 7877, introduced in the 119th Congress on March 9, 2026, aims to compel the Secretary of Health and Human Services to create a demonstration program that would assess the obligatory inclusion of wound care treatment for epidermolysis bullosa under the Medicaid program.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 7877

Bill HR 7877 is currently in the status of Bill Introduced since March 9, 2026. Bill HR 7877 was introduced during Congress 119 and was introduced to the House on March 9, 2026. Bill HR 7877's most recent activity was Sponsor introductory remarks on measure. (CR H2535) as of March 17, 2026

Bipartisan Support of Bill HR 7877

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 7877

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 7877

To require the Secretary of Health and Human Services to establish a demonstration program to test mandatory coverage of treatment for wound care for epidermolysis bullosa under the Medicaid program.

Comments

Giselle Lowe

769

2 months ago

I support this bill. What are the short term affects?

Truett Turner

891

2 months ago

I don't like it.

Amirah Maxwell

909

2 months ago

I don't think this bill is a good idea. It might cost too much money and I'm not sure if it will really help people with epidermolysis bullosa. I'm worried about how this could impact Medicaid in the long run.